CytoSMART Technologies appoints Supervisory Board members

Hits:763   Date: 6/23/2020

22nd June 2020, Eindhoven, The Netherlands – Life Science Newswire – CytoSMART Technologies has appointed Dr. Peter Djali and Bill Rhodes as Supervisory Board members.

Dr. Peter Djali has a longstanding track record in kinetic live-cell imaging. He was previously EU Sales Director at Essen Bioscience and Sales Manager at Molecular devices. Dr. Djali has a PhD in Molecular Physiology. 

Bill Rhodes is appointed as the Chairman of the Board. Mr. Rhodes previously worked as an Executive Officer of Becton Dickinson and Co. (NYSE:BDX) and Worldwide President of BD Biosciences. He is also Chairman of the Board of OpGen Inc. (NASDAQ:OPGN) and Interim Chairman of the Board of Omega Diagnostics Group plc (LON:ODX). He serves in various capacities with Cornell University, his alma mater, and is an advisor to Altaris Capital Partners, a New York City-based healthcare private equity firm. 
 

               

pictured: Dr Peter Djali                                            pictured: Bill Rhodes

 
About CytoSMART: CytoSMART Technologies is a company that develops and manufactures smart microscope systems for life science labs. The company was founded in 2012 by a team of biologists and engineers. They were convinced that a new generation of miniaturized microscopes, powered by artificial intelligence for image analysis, would allow biologists to make discoveries more quickly and in a reproducible manner. In 2018 CytoSMART was selected by Microsoft for its prestigious Scale Up program. CytoSMART’s microscopy solutions are used in over a thousand laboratories around the world. 
 
Contact information: 
Joffry Maltha, CEO
+31 88 203 2200
info@cytosmart.com